American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

About SESAP CME

Continuing Medical Education Credit Information

Accreditation

The American College of Surgeons is accredited by the ACCME to provide continuing medical education (CME) for physicians.

AMA PRA Category 1 Credits

The American College of Surgeons designates this enduring activity for a maximum of 109 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Of the AMA PRA Category 1 Credits™ listed above, a maximum of 109 credits meet the requirements for Self-Assessment.

Of the AMA PRA Category 1 Credits™ listed above, a maximum of 3 hours meet the requirements for Ethics.*

Of the AMA PRA Category 1 Credits™ listed above, a maximum of 8 hours meet the requirements for Surgical Critical Care.*

Of the AMA PRA Category 1 Credits™ listed above, a maximum of 9 hours meet the requirements for Trauma.*

*The content of this activity may meet certain mandates of regulatory bodies. Please note that the ACS has not and does not verify the content for such mandates with any regulatory body. Individual physicians are responsible for verifying the content satisfies such requirements.

CME Branding

Program Objectives

SESAP® 17 is intended for general surgeons. Upon completion of SESAP 17, participants should be able to:

  • Compare their cognitive knowledge at the beginning of the program with evidence-based surgical content for self-assessment and guided learning
  • Achieve and demonstrate mastery of surgical content to reach predetermined standards across all categories
  • Support lifelong excellence in surgery
  • Apply newly acquired knowledge to surgical practice
  • Keep current with surgical advances

Requirements to Earn 109 AMA PRA Category 1 Credits

To earn continuing medical education (CME) credit, participants must use the SESAP 17 CME Web version. SESAP 17 includes 650 questions across 13 categories, all of which must be completed to earn 109 CME credits. Individuals who subscribe by category can earn CME credit only for those categories. Credits assigned to each category are as follows:

Category

Number of Credits

Abdomen 17
Alimentary Tract 20
Breast 8
Endocrine 4
Head and Neck 3
Legal/Ethics 3
Oncology 3
Perioperative Care 20
Problems in Related Specialties 6
Skin/Soft Tissue 4
Surgical Critical Care 8
Trauma 9
Vascular Surgery 4

Participants enrolled for CME credit will be asked to read each question, select an answer, and review the corresponding critique and preferred answer. Participants will test their mastery of the content just learned by answering the same questions in a scrambled fashion and must achieve a cumulative score of 80 percent. If the score is less than 80 percent, the learner will be asked to review only the questions answered incorrectly and answer those questions again until a cumulative score of 80 percent is achieved. If a score of 80 percent correct is not achieved after the third round, the learner will be asked to start the entire section over again.

If a category has multiple parts, each part must be completed with a score of 80 percent to claim credit for the entire category. After achieving a score of 80 percent for each category, participants will be asked to complete an evaluation form and submit data to the American College of Surgeons (ACS) using the Internet. Upon successful submission, a CME certificate will be available to print. SESAP 17 is certified for credit through October 2022.

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the ACS must ensure that anyone in a position to control the content of the educational activity (planners and authors) has disclosed all financial relationships with any commercial interest, as defined as follows:

  • Commercial Interest: The ACCME defines a commercial interest as any entity producing, marketing, reselling, or distributing healthcare goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
  • Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
  • Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.

The ACCME also requires that the ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

Planning Committee

John A. Weigelt, MD, DVM, FACS, Chair (Nothing to disclose)
Richard M. Bell, MD, FACS (Nothing to disclose)
David C. Borgstrom, MD, MBA, FACS (Nothing to disclose)
David A. Bull, MD, FACS (Nothing to disclose)
Jeffrey G. Chipman, MD, FACS (Nothing to disclose)
Mary E. Fallat, MD, FACS (Nothing to disclose)
Jason B. Fleming, MD, FACS (Nothing to disclose)
Charles M. Friel, MD, FACS, FASCRS (Nothing to disclose)
Richard P. M. Koehler, MD, FACS (Nothing to disclose)
Lorrie A. Langdale, MD, FACS (Nothing to disclose)
Lena M. Napolitano, MD, FACS, FCCP, MCCM (Nothing to disclose)
John T. Paige, MD, FACS (Co-editor—Oxford University Press; FacultyHealth Resources and Services Administration; Co-Principal Investigator— Louisiana State University Board of Regents; Principal Investigator— Acell, Inc., Southern Group on Educational Affairs)
David A. Spain, MD, FACS (Nothing to disclose)
James G. Tyburski, MD, FACS (Nothing to disclose)
R. James Valentine, MD, FACS (Nothing to disclose)
Daniel Vargo, MD, FACS (Nothing to disclose)
John T. Vetto, MD, FACS (Spouse’s employer—Genentech, Inc.; Honorarium—Castle Biotech)
Travis P. Webb, MD, MHPE, FACS (Nothing to disclose)
Catherine M. Wittgen, MD, FACS (Consultant—Grafix, Organogenesis, Bristol Myers Squibb, CVRx, Inc.; Adjudicator—Bayer HealthCare Pharmaceuticals, Inc.; Speaker—Tactile Medical)

Authors

John A. Weigelt, MD, DVM, FACS, Chair (Nothing to disclose)
Richard M. Bell, MD, FACS (Nothing to disclose)
Frederic S. Bongard, MD, JD, FACS (Nothing to disclose)
David C. Borgstrom, MD, MBA, FACS (Nothing to disclose)
Tawnya L. Bowles, MD, FACS (Nothing to disclose)
David A. Bull, MD, FACS (Nothing to disclose)
Clay Cothren Burlew, MD, FACS (Nothing to disclose)
Casey M. Calkins, MD, FACS (Nothing to disclose)
Jeremy W. Cannon, MD, SM, FACS (Author –Up to Date, Inc.; Reviewer—US Department of Defense CDMRP)
Jeffrey G. Chipman, MD, FACS (Nothing to disclose)
Quyen D. Chu, MD, FACS (Nothing to disclose)
Jay J. Doucet, MD, MSc, FRCSC, FACS, RDMS (Nothing to disclose)
Dan Eisenberg, MD, MS, FACS, FASMBS (Nothing to disclose)
Mary E. Fallat, MD, FACS (Nothing to disclose)
Jason B. Fleming, MD, FACS (Nothing to disclose)
Charles M. Friel, MD, FACS, FASCRS (Nothing to disclose)
David A. Gerber, MD, FACS (Nothing to disclose)
Nicole S. Gibran, MD, FACS (Nothing to disclose)
Uzer Khan, MD, MBBS, FACS (Nothing to disclose)
Tari A. King, MD, FACS (Speaker—Genomic Health and Oncoclinicas)
Richard P. M. Koehler, MD, FACS (Nothing to disclose)
Mary R. Kwaan, MD, MPH, FACS (Nothing to disclose)
Lorrie A. Langdale, MD, FACS (Nothing to disclose)
Sean J. Langenfeld, MD, FACS, FASCRS (Nothing to disclose)
COL Robert B. Lim, MD, FACS (Consultant–Up to Date, Inc.)
Fred A. Luchette, MD, MSc, FACS (Nothing to disclose)
Linda L. Maerz, MD, FACS, FCCM (Nothing to disclose)
Linda W. Martin, MD, MPH, FACS (Speaker—American Society of Clinical Oncology)
David J. Milia, MD, FACS (Nothing to disclose)
Forrest O. Moore, MD, FACS (Editor—Wiley-Blackwell)
Nicholas Namias, MD, MBA, FACS, FCCM (Nothing to disclose)
Lena M. Napolitano, MD, FACS, FCCP, MCCM (Nothing to disclose)
Leigh A. Neumayer, MD, MS, FACS (Stockholder—Alphabet, Inc.; Celgene Corporation; Baidu, Inc.; Gilead Sciences, Inc.; Intrexon Corporation; Edwards Lifesciences; Regeneron Pharmaceuticals)
John T. Paige, MD, FACS (Co-editor—Oxford University Press; FacultyHealth Resources and Services Administration; Co-Principal Investigator— Louisiana State University Board of Regents; Principal Investigator— Acell, Inc., Southern Group on Educational Affairs)
Sharla Gayle Patterson, MD, MBA(HOM), FACS (Speaker’s bureau—Invuity, Inc.; Myriad Genetics, Inc.; Focal Therapeutics, Inc.; Medtronic; Committee member and course co-chair—American Society of Breast Surgeons)
Jasmeet S. Paul, MD, FACS (Nothing to disclose)
Daryl P. Pearlstein, MD, FACS (Consultant—Intuitive Surgical, Inc.)
Tam N. Pham, MD, FACS (Nothing to disclose)
Walter E. Pofahl II, MD, FACS (Nothing to disclose)
Trent D. Proehl, MD, FACS (Nothing to disclose)
Paul J. Schenarts, MD, FACS (Nothing to disclose)
David G. Sheldon, MD, FACS (Nothing to disclose)
Shayna L. Showalter, MD, FACS (Nothing to disclose)
Timothy R. Siegel, MD, FACS (Nothing to disclose)
David A. Spain, MD, FACS (Nothing to disclose)
Lance E. Stuke, MD, MPH, FACS (Nothing to disclose)
Kiran K. Turaga, MBBS, FACS (Consultant—Caris Life Sciences, Castle)
James G. Tyburski, MD, FACS (Nothing to disclose)
R. James Valentine, MD, FACS (Nothing to disclose)
Daniel Vargo, MD, FACS (Nothing to disclose)
John T. Vetto, MD, FACS (Spouse’s employer—Genentech, Inc.; Honorarium—Castle Biotech)
Tracy S. Wang, MD, MPH, FACS (Nothing to disclose)
Travis P. Webb, MD, MHPE, FACS (Nothing to disclose)
Catherine M. Wittgen, MD, FACS (Consultant—Grafix, Organogenesis, Bristol Myers Squibb, CVRx, Inc.; Adjudicator—Bayer HealthCare Pharmaceuticals, Inc.; Speaker—Tactile Medical)

Consultants

Ajit K. Sachdeva, MD, FACS, FRCSC, FSACME (Nothing to disclose)
Patrice Gabler Blair, MPH (Nothing to disclose)

Staff

Julia C. Dudek, MPH (Nothing to disclose)
Chrysa M. Cullather, MS (Nothing to disclose)
Katherine M. Greenock, MS (Nothing to disclose)

Education Credits of Excellence

Education Credits of Excellence are entirely optional and are designed to encourage further learning and to challenge surgeons who want to pursue a higher level of recognition. Surgeons are able and encouraged to study the items in the self-assessment portion as much as they wish prior to taking the CME test. Those surgeons who achieve 100 percent on the first attempt of the CME test for a category (or each part for categories with multiple parts) will receive a certificate for Education Credits of Excellence for that category. Education Credits of Excellence are being offered by the ACS Division of Education, as supported by the ACS Board of Regents. Certificates for Education Credits of Excellence may be accessed in the SESAP 17 web program.